PharmaCyte Biotech, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
PMCB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
23046 Avenida De La Carlota, Suite 600, Laguna Hills, CA

There are no Buy or Sell transactions made by insiders since 11/5/2023

PharmaCyte Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael M. Abecassis Director Apr 30, 2024
Raymond CF Tong Director Aug 10, 2021
Thomas Liquard Director Aug 10, 2021
Kenneth L. Waggoner Chairman, CEO, Pres and GC, Director Aug 10, 2021
Carlos Trujillo Chief Financial Officer, Director Nov 20, 2023
Matthias Loehr Director Mar 31, 2022
Daniel Stuart Farb Director Dec 28, 2022
Jonathan Schechter Director Apr 30, 2024
Daniel Allen Director Dec 28, 2022
Robert Weinstein Director Apr 30, 2024
Wayne R. Walker Director Apr 30, 2024
Gerald W. Crabtree Chief Science Officer, Director Aug 10, 2021
Thomas C. K. Yuen Director Aug 10, 2021
Jack E. Stover Director Aug 15, 2022
Joshua Silverman Interim CEO, Interim President, Director Nov 20, 2023

Recent Insider Transactions by Companies or Individuals for PharmaCyte Biotech, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.